Omeprazole
Who holds supplier records for Omeprazole? 32 organisations hold a current record for Omeprazole: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 25 of them hold a valid EU Certificate of Suitability (26 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (19), China (3), Spain (2), Netherlands (1) and 3 other countries (3); not recorded for 4.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Omeprazole: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/omeprazole
Reading the evidence
- 32 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
19 of the 28 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 19 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Omeprazole expires 8 Dec 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (32)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Omeprazole. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 12917, 24640, 19713 · latest filing Feb 2011
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 40894, 12827 · latest filing Dec 2024
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 25712, 15024 · latest filing Jan 2012
- SHOUGUANG FUKANG PHARMACEUTICAL CO LTDChinaCEP Company GMP cert on recordActive DMF 22897, 24923 · latest filing May 2011
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 21223 · latest filing Dec 2007
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaCEPActive DMF 38586 · latest filing Apr 2024
- ESTEVE QUIMICA SACEP Company GMP cert on recordActive DMF 11794, 11017 · latest filing Dec 1995
- Granules India LimitedIndiaCEP Company GMP cert on recordActive DMF 37449 · latest filing Sept 2022
- LEE PHARMA LTDIndiaCEP Company GMP cert on recordActive DMF 37921 · latest filing May 2023
- METROCHEM API PRIVATE LTDIndiaCEPActive DMF 27928, 34759 · latest filing Jun 2020
- Natco PharmaIndiaCEP Company GMP cert on recordActive DMF 21310 · latest filing Feb 2008
- QUIMICA SINTETICA SASpainCEP Company GMP cert on recordActive DMF 12605 · latest filing Jul 1997
- SRINI PHARMACEUTICALS PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 22471 · latest filing Jan 2009
- TAPI NL BVNetherlandsCEPActive DMF 25621 · latest filing Dec 2011
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)SpainCEPActive DMF 11551, 15804, 17255 · latest filing Mar 2004
- ZHEJIANG JINHUA CONBA BIO-PHARM CO LTDChinaCEP Company GMP cert on recordActive DMF 24118 · latest filing Sept 2010
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 21793 · latest filing Jul 2008
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 29633 · latest filing Oct 2015
- Everest Organics LimitedIndiaActive DMF 37155 · latest filing May 2022
- Lupin LimitedIndia Company GMP cert on recordActive DMF 21498 · latest filing Mar 2008
- RAKS PHARMA PVT LTDIndiaActive DMF 29402 · latest filing Jun 2015
- SRI SAI CHANDANA API PRIVATE LIMITEDIndiaActive DMF 44233 · latest filing Jul 2026
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 26796 · latest filing Mar 2013
- YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDActive DMF 28310 · latest filing Jul 2014
- SwedenCEP Company GMP cert on record
- NOSCH LABS PRIVATE LTDCEP Company GMP cert on record
- SCINOPHARM TAIWAN LTDTaiwanCEPInactive DMF 17392, 15949 · latest filing May 2004
- IndiaCEP
- Teva Pharmaceutical Industries Ltd.IsraelCEP Company GMP cert on record
- ULKAR KIMYA SANAYII VE TICARET ASCEP
- Zhejiang Huayi Pharmaceutical Co., Ltd.ChinaCEP
- SRISAICHANDANA API PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (26)
Certificates of Suitability on the EDQM register for Omeprazole, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 41 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SRISAICHANDANA API PRIVATE LIMITED Anakapalli District | IN | CEP 2024-472 - Rev 00 Omeprazole | Jun 2026 | — |
| CIPLA LIMITED Mumbai | IN | CEP 1997-122 - Rev 07 Omeprazole | Jun 2026 | — |
| ESTEVE QUIMICA S.A. Barcelona | ES | CEP 1998-145 - Rev 12 Omeprazole, Micronised and sieved grade | Feb 2026 | — |
| ZHEJIANG JINHUA CONBA BIO-PHARM. CO., LTD. Jinhua City | CN | CEP 2016-109 - Rev 02 Omeprazole | Jan 2026 | — |
| NOSCH LABS PRIVATE LIMITED Hyderabad | IN | CEP 2019-339 - Rev 01 Omeprazole | Nov 2025 | — |
| GRANULES INDIA LIMITED Hyderabad | IN | CEP 2022-406 - Rev 01 Omeprazole | Aug 2025 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2011-228 - Rev 03 Omeprazole, Process II | Aug 2025 | — |
| LEE PHARMA LIMITED Hyderabad | IN | CEP 2007-006 - Rev 05 Omeprazole, Micronised | Jul 2025 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2015-011 - Rev 03 Omeprazole, Form-B | May 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2011-065 - Rev 03 Omeprazole, Alternative process | Jan 2025 | — |
| CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram | IN | CEP 2023-238 - Rev 00 Omeprazole | Oct 2024 | — |
| METROCHEM API PRIVATE LIMITED Hyderabad | IN | CEP 2020-182 - Rev 01 Omeprazole | Jul 2024 | — |
| SHOUGUANG FUKANG PHARMACEUTICAL CO., LTD. Shouguang City | CN | CEP 2011-237 - Rev 01 Omeprazole, Process B | Jun 2024 | — |
| ZHEJIANG HUAYI PHARMACEUTICAL CO., LTD. Yiwu | CN | CEP 2012-326 - Rev 01 Omeprazole | Jan 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2008-075 - Rev 05 Omeprazole | Jan 2024 | — |
| Union Quimico Farmaceutica, S.A. (Uquifa S.A.) Barcelona | ES | R0-CEP 2022-120 - Rev 00 Omeprazole, Site II - Micronised and sieved grade | Sept 2022 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | R1-CEP 2011-162 - Rev 02 Omeprazole, Process II | Jul 2022 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | R1-CEP 2003-102 - Rev 03 Omeprazole | Jul 2022 | — |
| SRINI PHARMACEUTICALS PRIVATE LIMITED Choutuppal | IN | R1-CEP 2015-003 - Rev 00 Omeprazole | Dec 2021 | — |
| ASTRAZENECA AB Södertälje | SE | R1-CEP 2000-125 - Rev 06 Omeprazole | Oct 2020 | — |
| QUIMICA SINTETICA S.A. Alcala De Henares | ES | R1-CEP 1999-093 - Rev 08 Omeprazole | Feb 2019 | — |
| NATCO PHARMA LIMITED Hyderabad | IN | R1-CEP 2007-148 - Rev 02 Omeprazole | Feb 2017 | — |
| SMILAX LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2009-052 - Rev 00 Omeprazole | Sept 2015 | — |
| SCINOPHARM TAIWAN LTD. Shan-Hua | TW | R1-CEP 2003-268 - Rev 03 Omeprazole | Apr 2013 | — |
| Teva Pharmaceutical Industries Ltd. Petach Tikva | IL | R1-CEP 2002-112 - Rev 03 Omeprazole | Mar 2013 | — |
| Ulkar Kimya Sanayii Ve Ticaret Anonim Sirketi Umraniye | TR | R1-CEP 2000-157 - Rev 03 Omeprazole | Feb 2013 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Omeprazole are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- India · Inactive DMF 26262 · filed Jul 2012
- India · Inactive DMF 23219 · filed Oct 2009
- India · Inactive DMF 18501 · filed Jul 2005
- SANDOZ SYNTEK ILAC HAMMADDELERI SANAYI VE TICARET ASInactive DMF 17126 · filed Jan 2004
- SANYO FINE CO LTDInactive DMF 14969 · filed Jul 2000
- India · Inactive DMF 14286 · filed Jul 1999
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (53 listed products contain Omeprazole). The latest listed patent expires 8 Dec 2036. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Omeprazole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1503).
Chemical identity
- IUPAC name
- 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole
- Canonical SMILES
- CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC
- InChIKey
- SUBDBMMJDZJVOS-UHFFFAOYSA-N
- Synonyms
- Antra, H 168/68, H-168/68, Losec, Losec mups, Mezzopram, Mopral, NSC-751450, NSC-759192, Omeprazol, Omeprazole, Omeprazole component of konvomep
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Proton Pump Inhibitor
- Mechanism of action
- Cytochrome P450 2C19 Inhibitors; Proton Pump Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Omeprazole?
32 organisations hold an active US FDA Type II Drug Master File or a CEP for Omeprazole: Dr. Reddy's Laboratories Ltd. (India), Cipla Limited (India), Hetero Drugs Limited (India), SHOUGUANG FUKANG PHARMACEUTICAL CO LTD (China), APITORIA PHARMA PRIVATE LTD (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), ESTEVE QUIMICA SA and Granules India Limited (India), and 24 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Omeprazole Drug Master Files are active?
Dr. Reddy's Laboratories Ltd. (DMF 12917, 24640), Cipla Limited (DMF 40894, 12827), Hetero Drugs Limited (DMF 25712, 15024), SHOUGUANG FUKANG PHARMACEUTICAL CO LTD (DMF 22897, 24923), APITORIA PHARMA PRIVATE LTD (DMF 21223), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 38586), ESTEVE QUIMICA SA (DMF 11794, 11017) and Granules India Limited (DMF 37449) and 16 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Omeprazole records mean?
6 organisations have only inactive Type II DMFs for Omeprazole. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Omeprazole have a European Certificate of Suitability?
Yes. 25 organisations hold a valid CEP for Omeprazole on the EDQM register, including SRISAICHANDANA API PRIVATE LIMITED Anakapalli District (IN), CIPLA LIMITED Mumbai (IN), ESTEVE QUIMICA S.A. Barcelona (ES), ZHEJIANG JINHUA CONBA BIO-PHARM. CO., LTD. Jinhua City (CN), NOSCH LABS PRIVATE LIMITED Hyderabad (IN) and GRANULES INDIA LIMITED Hyderabad (IN) and 20 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Omeprazole?
Yes. The latest patent listed for an approved US product containing Omeprazole expires 8 Dec 2036, across 53 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Omeprazole supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Omeprazole?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.